Jerusalem Pharmaceuticals Ratios and Metrics

Market cap in millions JOD. Fiscal year is January - December.

Millions JOD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	94	59	49	49	42	36
Market Cap Growth	94.37%	20.04%	0.69%	15.82%	16.13%	2.15%
Enterprise Value	89	53	43	41	39	37
Last Close Price	2.62	1.59	1.30	1.25	1.04	0.86
PE Ratio	13.04	8.13	13.68	9.83	8.23	7.72
PS Ratio	2.65	1.69	1.73	1.73	1.28	1.10
PB Ratio	1.47	0.94	0.96	0.99	0.91	0.74
P/TBV Ratio	1.54	0.98	1.00	1.03	0.94	0.80
P/FCF Ratio	-	51.39	6.94	8.72	3.62	13.20
P/OCF Ratio	-	22.87	5.87	7.44	3.47	8.42
EV/Sales Ratio	2.49	1.53	1.52	1.47	1.18	1.12
EV/EBITDA Ratio	8.21	5.19	7.64	5.73	5.19	5.20
EV/EBIT Ratio	9.35	5.81	9.05	6.49	6.20	6.48
EV/FCF Ratio	-	46.32	6.10	7.44	3.35	13.40
Debt / Equity Ratio	0.03	0.02	0.02	0.04	0.03	0.04
Debt / EBITDA Ratio	0.15	0.09	0.18	0.23	0.20	0.25
Debt / FCF Ratio	-	0.82	0.15	0.32	0.13	0.68
Net Debt / Equity Ratio	-0.10	-0.12	-0.14	-0.06	-0.09	-0.04
Net Debt / EBITDA Ratio	-0.62	-0.76	-1.29	-0.41	-0.53	-0.29
Net Debt / FCF Ratio	2.76	-6.76	-1.03	-0.53	-0.34	-0.74
Asset Turnover	0.48	0.48	0.45	0.47	0.54	0.56
Inventory Turnover	1.95	1.97	2.10	1.72	1.79	1.61
Quick Ratio	2.55	2.57	3.33	2.97	2.88	2.80
Current Ratio	3.42	3.41	4.29	4.11	3.86	4.25
Return on Equity (ROE)	12.59%	12.84%	7.21%	10.45%	10.77%	9.55%
Return on Assets (ROA)	8.02%	7.88%	4.77%	6.60%	6.45%	6.06%
Return on Invested Capital (ROIC)	13.40%	14.81%	8.13%	11.48%	11.22%	10.07%
Return on Capital Employed (ROCE)	13.70%	13.50%	8.70%	12.10%	12.60%	10.80%
Earnings Yield	7.67%	12.30%	7.31%	10.17%	12.15%	12.95%
FCF Yield	-2.52%	1.95%	14.42%	11.46%	27.64%	7.58%
Dividend Yield	2.01%	3.34%	2.19%	2.83%	5.10%	4.92%
Payout Ratio	13.43%	13.59%	33.52%	36.63%	29.90%	20.25%
Total Shareholder Return	-12.34%	3.34%	2.19%	2.83%	5.10%	4.92%